Morgan Stanley reiterated an overweight rating for Monster Beverage. The firm set a $103 price target. Morgan Stanley cited confidence in Monster's growth prospects. It highlighted Monster's innovation pipeline as the strongest in its history. This pipeline could drive sustained revenue growth and market share gains.
New products launched since late 2025 account for approximately 14.5% of Monster's U.S. sales. This new product wave is diverse. It includes limited editions like Ultra Red, White and Blue Razz. New brand launches include FLRT. The company also introduced successful European products to the U.S.
Morgan Stanley believes this expanded strategy will enable Monster to attract new consumers. It also expects expansion into different sales channels. Successful U.S. launches could roll out internationally. This offers another significant avenue for future growth.